Hermann Eye Center
6400 Fannin Ste 1800, Texas, 77030, United States
Completed
NCT Number: NCT00567177
Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
We propose to investigate the response to Restasis, over a prolonged period of time in heavy computer users with dry eye disease.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
13 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Using computers more than three hours per day
- Having dry eye symptoms based on results on the OSDI Scores of 15 or greater on the OSDI will be considered to have the disorder
- An abnormal confocal image of 5 or greater.
Exclusion criteria
- All corneal disorders except for tear disorders.
Treatment and study plan
Restasis, Refresh Plus
DrugRestasis 0.4ml- (in the eye) Instill one drop twice daily in morning and evening Refresh Plus 0.4ml- (in the eye) Instill one drop twice daily in morning and evening
Primary outcomes
-
Dry Eye disease
Time frame: 6 months
Secondary outcomes
-
efficacy
Time frame: 6 months
Sponsors and collaborators
Lead sponsor
Innovative Medical
Industry
Registry information
Important dates
- Study start
- 2007
- Study completion
- 2008
- First posted
- Dec 4, 2007
- Registry last updated
- Jul 30, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.